Detalhe da pesquisa
1.
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Int J Mol Sci;
25(5)2024 Feb 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38473874
2.
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review.
BMC Cancer;
23(1): 748, 2023 Aug 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37573294
3.
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
J Natl Compr Canc Netw;
: 1-9, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34560672
4.
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost-benefit analysis.
Lancet Oncol;
21(5): 664-670, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32359489
5.
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
Cancer;
126(19): 4390-4399, 2020 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32697362
6.
Safety-Related Postmarketing Modifications of Drugs for Hematological Malignancies.
Acta Haematol;
143(1): 73-77, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31167178
7.
Global cooperation and early access-clinical outcomes matter.
Lancet Oncol;
25(6): 687-688, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38754452
8.
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Cancer;
125(22): 4069-4075, 2019 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31355923
9.
Reforms to accelerated approval of new medicines: long overdue.
Lancet;
400(10349): 357-358, 2022 07 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35835129
10.
Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies.
JAMA Oncol;
10(5): 634-641, 2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38573645
11.
Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.
Cancer Treat Rev;
122: 102666, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38064877
12.
Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer.
Breast Cancer Res Treat;
141(3): 485-93, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24072269
13.
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients.
Biomedicines;
11(12)2023 Dec 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38137452
14.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol;
15: 17588359221148921, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36743520
15.
Clinical benefit of cancer drugs approved in Switzerland 2010-2019.
PLoS One;
17(6): e0268545, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35687539
16.
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia.
JCO Oncol Pract;
18(9): e1522-e1532, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35731996
17.
Association between control group therapy and magnitude of clinical benefit of cancer drugs.
Sci Rep;
12(1): 21342, 2022 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36494465
18.
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
Clin Cancer Res;
28(1): 106-115, 2022 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34615719
19.
The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis.
Cancer Treat Rev;
100: 102293, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34543860
20.
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations.
Cancer Med;
10(16): 5405-5414, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34323019